Showing results (91-100 of 148) with videos related to
Sort By:
Pageof 15
American Journal of Clinical Pathology|May 7, 1999
Medical and economic benefit of a comprehensive infection control program that includes routine determination of microbial clonalityD M Hacek, T Suriano, G A Noskin, et al.Alzheimer Disease and Associated Disorders|January 1, 1992
Management of behavior disturbance in Alzheimer disease: current knowledge and future directionsL Teri, P Rabins, P Whitehouse, et al.Pharmacology, Biochemistry, and Behavior|June 1, 1983
Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the ratC Flicker, R L Dean, D L Watkins, et al.Pharmacology, Biochemistry, and Behavior|May 1, 1986
Behavioral recovery following bilateral lesions of the nucleus basalis does not occur spontaneouslyR T Bartus, M J Pontecorvo, C Flicker, et al.Journal of Neural Transmission. Supplementum|November 29, 2002
Measuring cognition in advanced Alzheimer's disease for clinical trialsF A Schmitt, D Cragar, J W Ashford, et al.The Journal of Endocrinology|February 1, 1981
Changes in membrane potential of cultured porcine and human thyroid cells in response to thyrotrophin and other agentsJ R Bourke, K L Carseldine, S H Ferris, et al.The Journal of Clinical Psychiatry|May 1, 1996
Staging methods for the assessment of dementia: PerspectivesJ Cohen-Mansfield, B Reisberg, J Bonnema, et al.Acta Neuropathologica|March 21, 2002
Vascular fibrosis and calcification in the hippocampus in aging, Alzheimer disease, and Down syndromeJ Wegiel, I Kuchna, T Wisniewski, et al.Brain Research|July 17, 1998
Duration of neurofibrillary changes in the hippocampal pyramidal neuronsM Bobinski, J Wegiel, M Tarnawski, et al.Brain Research|September 12, 1998
Neuronal and volume loss in CA1 of the hippocampal formation uniquely predicts duration and severity of Alzheimer diseaseM Bobinski, M J de Leon, M Tarnawski, et al.Pageof 15